BioPharmSignal logoBioPharmSignal

Biotech News

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance

Aveanna Healthcare (AVAH)Aveanna HealthcareEarnings

Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period Second Quarter Net income was $40.3 million compared to $27.0 million for the prior year period Adjusted EBITDA for Q2 2026 was $95.4 million, an 8.0% increase over the prior year period Increased Full Year 2026

Related news

AVAHAveanna Healthcare2026-05-14 11:00 EST

Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance

AVAHAveanna Healthcare2026-03-19 11:00 EST

Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

View all latest news

Aveanna Healthcare

Home-Based Healthcare Provider Aveanna Healthcare provides pediatric and adult home-care services to medically complex patients in the United States. Private Duty Services The company’s largest business delivers private duty nursing and other care for patients requiring sustained clinical support at home. Home Health and Hospice Aveanna...

Recent company news

AVAHAveanna Healthcare2026-08-21 00:17 EST

Aveanna Announces Pricing of Secondary Offering of Common Stock

AVAHAveanna Healthcare2026-08-20 20:10 EST

Aveanna Announces Launch of Secondary Offering of Common Stock

AVAHAveanna Healthcare2026-08-13 11:00 EST

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance

AVAHAveanna Healthcare2026-07-23 10:30 EST

Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call

AVAHAveanna Healthcare2026-06-02 11:30 EST

Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance

Stock data

Close
13.16 USD
Market cap
1.41B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States